Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free URGN Stock Alerts

Urogen Pharma (URGN) Stock Chart & Stock Price History

Urogen Pharma logo
$42.78 +1.66 (+4.02%)
As of 10:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Urogen Pharma Stock Price Performance

The Urogen Pharma (URGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 176.68%, with a year-to-date return of 82.64%. In the past month, the stock has increased 27.42%, reflecting recent market activity.

As of the latest close, Urogen Pharma traded at $41.12 with a market cap of $2.00 billion and volume of 550,404 shares. Five years ago, the stock traded at $15.95, representing a 168.18% increase over that period. At the time, it had a market cap of $333.31 million and a volume of 151,364 shares.

Receive URGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+6.94%
1 Month
Performance
+27.42%
3 Month
Performance
+70.89%
Year-To-Date
Performance
+82.64%
1 Year
Performance
+176.68%
5 Year
Performance
+168.18%

URGN Stock Chart for Tuesday, July, 21, 2026

URGN Chart by TradingView

Urogen Pharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
07/20/2026$40.23$41.12
+2.21%		$41.92$40.23550,404 shs$2.00 billion
07/17/2026$40.00$40.23
+0.57%		$41.88$39.501.27 million shs$1.96 billion
07/16/2026$39.80$40.00
+0.50%		$41.36$39.541.24 million shs$1.95 billion
07/15/2026$39.19$39.80
+1.56%		$40.87$38.30907,816 shs$1.94 billion
07/14/2026$39.51$39.19
-0.81%		$40.40$38.88556,070 shs$1.91 billion
07/13/2026$38.56$39.51
+2.46%		$40.00$36.81577,222 shs$1.92 billion
07/10/2026$40.23$38.56
-4.15%		$40.35$38.281.28 million shs$1.88 billion
07/09/2026$38.03$40.23
+5.78%		$40.34$38.11617,932 shs$1.96 billion
07/08/2026$37.75$38.03
+0.74%		$38.56$36.55715,851 shs$1.85 billion
07/07/2026$37.41$37.75
+0.91%		$39.12$36.68914,044 shs$1.84 billion
07/06/2026$38.02$37.41
-1.60%		$38.59$37.23845,634 shs$1.82 billion
07/03/2026$38.02$38.02$38.58$36.88821,799 shs$1.85 billion
07/02/2026$37.94$38.02
+0.21%		$38.58$36.88821,799 shs$1.85 billion
07/01/2026$36.80$37.94
+3.10%		$39.59$37.111.13 million shs$1.85 billion
06/30/2026$36.07$36.80
+2.02%		$37.88$35.82670,538 shs$1.79 billion
06/29/2026$34.54$36.07
+4.43%		$36.67$34.10600,249 shs$1.76 billion
06/26/2026$34.38$34.54
+0.47%		$35.10$33.731.35 million shs$1.68 billion
06/25/2026$35.42$34.38
-2.94%		$36.00$34.22414,606 shs$1.67 billion
06/24/2026$35.15$35.42
+0.77%		$36.08$34.61581,790 shs$1.73 billion
06/23/2026$34.99$35.15
+0.46%		$35.58$34.19465,289 shs$1.71 billion
06/22/2026$33.57$34.99
+4.23%		$35.35$33.70624,535 shs$1.70 billion
Related Companies

This page (NASDAQ:URGN) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel